Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 264
Selected: 0
NCT IDTitle
NCT06756802Reproductive Health in Breast Cancer Survivor
NCT04115007Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients
NCT02817958Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis
NCT02980510Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients
NCT07437287Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers
NCT07360834Study Aiming to Test Whether Non-invasive Liquid Biopsies Can Safely Reduce Invasive Surveillance Methods in Lynch Syndrome
NCT00820547Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients
NCT03946033Impact of Immunoscore Colon Test on Adjuvant Therapeutic Strategy in Non-Metastatic Colon Cancer
NCT03013335Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen
NCT00003852Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
NCT03012581Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
NCT03132038Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck
NCT02404935Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC)
NCT01022918Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
NCT00004205Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
NCT05078047Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
NCT03438552Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
NCT01247233Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer
NCT00104702Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer
NCT02215265Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
NCT05552001Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer
NCT01675999Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer
NCT03275311Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
NCT05973864Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
NCT03672331My Personalized Breast Screening
NCT00005944Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer
NCT03532204Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer
NCT02773004Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer
NCT00005584Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
NCT05476796Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer
NCT00006051Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
NCT03676257Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases
NCT03011528First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3)
NCT00227708Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT00967863Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)
NCT00003607Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
NCT06606730Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer
NCT03275298Evolution of the Therapeutic Care in Ovarian Cancer From 2011
NCT03079011PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection
NCT06276465Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
NCT00630032Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer
NCT03777813Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer
NCT00003650Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
NCT00104715Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
NCT01376752Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment
NCT06078384Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC
NCT04450836Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer
NCT00003682Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer
NCT05974774Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
NCT00083174Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer